Xenon Pharmaceuticals (XENE) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.82
-0.75
-0.69
-0.62

Details

Expected EPS
-0.815591
Actual EPS
-0.81
Surprise EPS
0.01
Surprise Percent
+0.69%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -0.81 per share for Q4 2024.

0 Comments

Share your thoughts